1. Home
  2. PLSE vs NCDL Comparison

PLSE vs NCDL Comparison

Compare PLSE & NCDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • NCDL
  • Stock Information
  • Founded
  • PLSE 2014
  • NCDL 2019
  • Country
  • PLSE United States
  • NCDL United States
  • Employees
  • PLSE N/A
  • NCDL N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • NCDL
  • Sector
  • PLSE Health Care
  • NCDL
  • Exchange
  • PLSE Nasdaq
  • NCDL NYSE
  • Market Cap
  • PLSE 1.1B
  • NCDL 929.5M
  • IPO Year
  • PLSE 2016
  • NCDL N/A
  • Fundamental
  • Price
  • PLSE $17.23
  • NCDL $16.71
  • Analyst Decision
  • PLSE
  • NCDL Buy
  • Analyst Count
  • PLSE 0
  • NCDL 6
  • Target Price
  • PLSE N/A
  • NCDL $18.33
  • AVG Volume (30 Days)
  • PLSE 170.0K
  • NCDL 313.7K
  • Earning Date
  • PLSE 10-30-2024
  • NCDL 02-22-2025
  • Dividend Yield
  • PLSE N/A
  • NCDL 8.04%
  • EPS Growth
  • PLSE N/A
  • NCDL N/A
  • EPS
  • PLSE N/A
  • NCDL N/A
  • Revenue
  • PLSE N/A
  • NCDL N/A
  • Revenue This Year
  • PLSE N/A
  • NCDL N/A
  • Revenue Next Year
  • PLSE N/A
  • NCDL N/A
  • P/E Ratio
  • PLSE N/A
  • NCDL N/A
  • Revenue Growth
  • PLSE N/A
  • NCDL N/A
  • 52 Week Low
  • PLSE $6.60
  • NCDL $16.00
  • 52 Week High
  • PLSE $22.69
  • NCDL $18.10
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 48.98
  • NCDL 45.13
  • Support Level
  • PLSE $16.97
  • NCDL $16.50
  • Resistance Level
  • PLSE $18.48
  • NCDL $17.15
  • Average True Range (ATR)
  • PLSE 1.27
  • NCDL 0.22
  • MACD
  • PLSE -0.09
  • NCDL -0.02
  • Stochastic Oscillator
  • PLSE 31.17
  • NCDL 47.93

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About NCDL NUVEEN CHURCHILL DIRECT LENDNG CORP

Nuveen Churchill Direct Lending Corp is a specialty finance company focused predominantly on investing in senior secured loans to private equity-owned U.S. middle market companies. It invest in senior secured loans that typically pay floating interest rates and are senior in the capital structure to junior debt and equity.

Share on Social Networks: